missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30025801

PRKD3/nPKC nu Antibody (OTI3D8), PerCP, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-73595PCP

Product Code. 30025801

  • € 740.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

PRKD3/nPKC nu Monoclonal antibody specifically detects PRKD3/nPKC nu in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

PRKD3/nPKC nu
Monoclonal
PerCP
PBS
Mouse
Immunogen affinity purified
RUO
Primary
Human, Mouse, Rat
Purified
Western Blot, Immunohistochemistry
OTI3D8
Western Blot, Immunohistochemistry
EC 2.7.11, EC 2.7.11.13, EPK2PKD3, nPKC-nu, PKC-NU, PRKCNnPKC-NU, Protein kinase C nu type, protein kinase C, nu, protein kinase D3, Protein kinase EPK2, protein-serine/threonine kinase, serine/threonine-protein kinase D3
Human recombinant protein fragment corresponding to amino acids 300-508 of human PRKD3 (NP_005804) produced in E.coli.
0.1 mL
Cancer, Diabetes Research, Phospho Specific, Protein Kinase, Signal Transduction, Transcription Factors and Regulators
23683
Store at 4C in the dark.
IgG2b
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.